ES2667011T3 - Monoacilgliceroles sn-2 y malabsorción lipídica - Google Patents

Monoacilgliceroles sn-2 y malabsorción lipídica Download PDF

Info

Publication number
ES2667011T3
ES2667011T3 ES10168420.7T ES10168420T ES2667011T3 ES 2667011 T3 ES2667011 T3 ES 2667011T3 ES 10168420 T ES10168420 T ES 10168420T ES 2667011 T3 ES2667011 T3 ES 2667011T3
Authority
ES
Spain
Prior art keywords
monoacylglycerols
positions
lipid malabsorption
protective
malabsorption
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10168420.7T
Other languages
English (en)
Inventor
Bruce Bistrian
Frédéric DESTAILLATS
Cristina Cruz-Hernandez
Fabiola Dionisi
Isabelle Masserey-Elmelegy
Manuel Oliveira
Julie Céline Moulin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Beth Israel Deaconess Medical Center Inc
Original Assignee
Nestec SA
Beth Israel Deaconess Medical Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec SA, Beth Israel Deaconess Medical Center Inc filed Critical Nestec SA
Application granted granted Critical
Publication of ES2667011T3 publication Critical patent/ES2667011T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)

Abstract

Composición que comprende un derivado monoacilglicerol sn-2, en la que las posiciones sn-1 y sn-3 se encuentran bloqueadas por grupos protectores, en la que el grupo acilo es un ácido graso que presenta propiedades antiinflamatorias y en la que el grupo protector es la vainillina, que establece puentes entre los grupos hidroxilo en las posiciones sn-1 y sn-3.

Description

imagen1
imagen2
imagen3
imagen4
imagen5

Claims (1)

  1. imagen1
ES10168420.7T 2010-07-05 2010-07-05 Monoacilgliceroles sn-2 y malabsorción lipídica Active ES2667011T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10168420.7A EP2409695B1 (en) 2010-07-05 2010-07-05 Sn-2-monoacylglycerols and lipid malabsorption

Publications (1)

Publication Number Publication Date
ES2667011T3 true ES2667011T3 (es) 2018-05-09

Family

ID=42669828

Family Applications (2)

Application Number Title Priority Date Filing Date
ES10168420.7T Active ES2667011T3 (es) 2010-07-05 2010-07-05 Monoacilgliceroles sn-2 y malabsorción lipídica
ES11729629T Active ES2769296T3 (es) 2010-07-05 2011-07-05 Monoacilgliceroles sn-2 y malabsorción de lípidos

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES11729629T Active ES2769296T3 (es) 2010-07-05 2011-07-05 Monoacilgliceroles sn-2 y malabsorción de lípidos

Country Status (8)

Country Link
US (5) US20130109753A1 (es)
EP (2) EP2409695B1 (es)
JP (1) JP6157349B2 (es)
CN (1) CN103002889B (es)
DK (2) DK2409695T3 (es)
ES (2) ES2667011T3 (es)
TR (1) TR201808471T4 (es)
WO (1) WO2012004234A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY162797A (en) 2010-12-29 2017-07-14 Abbott Lab Nutritional products including a novel fat system including monoglycerides
EP2508180A1 (en) * 2011-04-04 2012-10-10 Nestec S.A. Sn-1(3) Monoacylglycerides and lipid absorption
JP6456302B2 (ja) 2013-02-11 2019-01-23 フィリップス ライティング ホールディング ビー ヴィ フェノキシ置換ペリレン−３，４，９，１０−テトラカルボン酸ジイミド有機赤色放出体及びそれを用いた発光デバイス
US20160199338A1 (en) * 2013-08-19 2016-07-14 Enzychem Lifesciences Corporation Compositions containing monoacetyldiacylglycerol compound as an active ingredient for preventing or treating rheumatoid arthritis
ES2902679T3 (es) * 2013-08-19 2022-03-29 Enzychem Lifesciences Corp Composición que contiene compuesto de monoacetildiacilglicerol como principio activo para prevenir o tratar el asma
EP3042651B1 (en) * 2013-09-03 2020-01-01 Enzychem Lifesciences Corporation Composition containing monoacetyldiacylglycerol compound as active ingredient for preventing or treating atopic dermatitis
CA2924004A1 (en) * 2013-10-28 2015-05-07 Nestec S.A. Monoacylglycerols and fat-soluble nutrients for use in the treatment of maldigestion
US20160263072A1 (en) * 2013-10-28 2016-09-15 Nestec S.A. Monoacylglycerols and fat-soluble nutrients for use in the treatment of malabsorption having a non-mechanical basis
AU2015340903A1 (en) * 2014-10-27 2017-04-06 Société des Produits Nestlé S.A. Nutritional compositions comprising sn-1 (3) monoacylglycerols for use in the treatment of malabsorption or maldigestion in infants or young children
EP3317385B1 (en) 2015-07-02 2019-04-03 Stepan Company Method for preparing 2-monoacylglycerides

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59190948A (ja) * 1983-04-14 1984-10-29 ルセル―ユクラフ 新規なトリグリセリド、その製造法、食餌療法及び治療法への使用並びにそれを含む組成物
JPS6387988A (ja) * 1986-10-01 1988-04-19 Nisshin Oil Mills Ltd:The 消化吸収性の良い油脂
JPH04316539A (ja) * 1991-05-23 1992-11-06 Roussel Uclaf 新規なトリグリセリド、その製造法、食餌療法及び治療法への使用並びにそれを含む組成物
EP1090636A1 (en) * 1999-09-13 2001-04-11 Société des Produits Nestlé S.A. High lipid diet
FR2833606B1 (fr) * 2001-12-19 2004-02-13 Inst Francais Du Petrole Compositions de carburants diesel contenant des carbonates d'acetals de glycerol
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
DE112004001520B4 (de) * 2003-08-18 2008-04-10 Btg International Ltd. Verwendung eines Lipidglyzerids festgelegter Struktur zur Herstellung eines Medikamentes zur Behandlung der multiplen Sklerose
JP2005225863A (ja) * 2004-01-16 2005-08-25 Fuji Oil Co Ltd リパーゼ阻害剤
KR20060124679A (ko) * 2004-01-16 2006-12-05 후지 세이유 가부시키가이샤 리파아제 저해제
GB0504362D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
EP1774973A1 (en) * 2005-10-12 2007-04-18 Nutricia N.V. Leucine rich composition
JP2009084230A (ja) * 2007-10-01 2009-04-23 Idemitsu Kosan Co Ltd 炎症抑制剤

Also Published As

Publication number Publication date
US20150224079A1 (en) 2015-08-13
US10039742B2 (en) 2018-08-07
CN103002889B (zh) 2017-03-29
WO2012004234A1 (en) 2012-01-12
JP6157349B2 (ja) 2017-07-05
US20170296507A1 (en) 2017-10-19
EP2590644A1 (en) 2013-05-15
US9034917B2 (en) 2015-05-19
EP2590644B1 (en) 2020-01-01
EP2409695A1 (en) 2012-01-25
DK2590644T3 (da) 2020-02-17
TR201808471T4 (tr) 2018-07-23
ES2769296T3 (es) 2020-06-25
DK2409695T3 (en) 2018-05-28
US9687462B2 (en) 2017-06-27
CN103002889A (zh) 2013-03-27
US20140142169A1 (en) 2014-05-22
JP2013530999A (ja) 2013-08-01
US9522132B2 (en) 2016-12-20
US20170056362A1 (en) 2017-03-02
EP2409695B1 (en) 2018-03-21
US20130109753A1 (en) 2013-05-02

Similar Documents

Publication Publication Date Title
ES2667011T3 (es) Monoacilgliceroles sn-2 y malabsorción lipídica
WO2016100634A3 (en) Composition for enhancing hair fiber properties
FR3029781B1 (fr) Composition comprenant de l'hesperetine, une huile, au moins un ester d'acide gras et de (poly)glycerol, un polyol
PE20181493A1 (es) Profarmaco de adrenomedulina basado en polietilenglicol y su uso
AR097214A1 (es) Composiciones edulcorantes
CO6341615A2 (es) Salicilatos acetilados con acidos grasos y sus usos.
RU2015134141A (ru) Композиции твердых растворов и их применение при хроническом воспалении
CL2008003284A1 (es) Compuestos derivados de 4-bencilamino-1-carboxiacil-piridina, inhibidores cetp; composicion farmaceutica que los comprende; combinacion farmaceutica; y uso en el tratamiento de enfermedades metabolicas, ateroesclerosis y cardiovasculares, entre otras.
AR069474A1 (es) Material anticorrosivo
BRPI0817826A2 (pt) Formulações herbicidas de éster de fluroxipir meptila com c4-c8 ésteres de triclopir, 2,4-d ou mcpa isentas de solvente aromático.
CL2008003540A1 (es) Composición saborizante para lechones que comprende propilénglicol, vainillina, gama-nonalactona, un éster alquílico de ácido acético, un aceite esencial de naranja, un éster alquílico de ácido benzoico, un éster alquílico de ácido cinámico, un butirato de bencilo y uno o dos ésteres alquílicos de ácido butírico.
ES2598036T3 (es) Plataforma de apoyo para apoyar al menos un grupo en un submarino
ES2669311T3 (es) Incremento de la biodisponibilidad de los ácidos hidroxicinámicos
RU2017115933A (ru) Композиция состава для наружного применения, содержащая s-флурбипрофен
ES2512215B1 (es) Sistema de elevación mecánico perfeccionado de pasarelas de embarque
CY1114036T1 (el) Φαρμακοτεχνικη μορφη που περιεχει κετοπροφενη και εναν εστερα πολυοξυαλκυλενιου ενος υδροξυ λιπαρου οξεος
AR116761A2 (es) Lípido que comprende ácidos grasos poliinsaturados de cadena larga
TH168503A (th) การกำจัดกรดไขมันอิสระจากน้ำมันกลีเซอไรด์
CL2013003046A1 (es) Formulacion antigenica que comprende un aceite que contiene un éster de ácido eleosteárico.
TH11615C3 (th) ชุดทดสอบค่าปริมาณร้อยละโดยน้ำหนักเมทิลเอสเทอร์ของไบโอดีเซลประเภท อัลคิลเอสเทอร์โดยใช้เทคนิคทินเลเยอร์โครมาโตกราฟฟี (tlc) และรังสียูวี (uv)
TH11615A3 (th) ชุดทดสอบค่าปริมาณร้อยละโดยน้ำหนักเมทิลเอสเทอร์ของไบโอดีเซลประเภท อัลคิลเอสเทอร์โดยใช้เทคนิคทินเลเยอร์โครมาโตกราฟฟี (tlc) และรังสียูวี (uv)
TH104629S (th) ชิ้นส่วนทุ่นรองรับกังหัน
TH39330S1 (th) ชิ้นส่วนทุ่นรองรับกังหัน
TH106045S (th) อุปกรณ์ขึ้นรูปแผ่นฟิล์ม
TH11986A3 (th) ระบบผลิตแก๊สชีวมวล